Literature DB >> 9536825

Microvascular involvement in systemic sclerosis: laser Doppler evaluation of reactivity to acetylcholine and sodium nitroprusside by iontophoresis.

L La Civita1, M Rossi, G Vagheggini, F A Storino, L Credidio, G Pasero, C Giusti, C Ferri.   

Abstract

OBJECTIVES: To investigate the skin vasodilatory response to iontophoretically applied acetylcholine (Ach), an endothelium dependent vasodilator, and to sodium nitroprusside (SNP), an endothelium independent vasodilator, in patients with systemic sclerosis (SSc).
METHODS: Eleven SSc patients were preliminarily studied (10 females, mean age 40.5; mean disease duration 6.5 years), and 16 age and sex matched control subjects. By means of laser Doppler flowmetry skin blood flow was evaluated at third finger, at baseline, and after postischaemic hyperaemia test and during iontophoretically transcutaneous application of 1% solution of Ach and SNP.
RESULTS: No significant differences in basal skin blood flow were detected between SSc patients and controls. Cutaneous vasodilatory response to ischaemia, Ach, and SNP was significantly less pronounced in SSc patients compared with controls (p < 0.001). Moreover, among SSc patients a lower (p < 0.05) vasodilatory response to Ach compared with ischaemia and SNP was recorded.
CONCLUSIONS: These data confirm a reduction of skin digital vasodilatory reserve in SSc patients and suggest a defect of both endothelial dependent arteriolar relaxation and wall compliance in the pathogenesis of this dysfunction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9536825      PMCID: PMC1752467          DOI: 10.1136/ard.57.1.52

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

1.  Iontophoretic evaluation of vascular reactivity to acetylcholine in patients with primary Raynaud's phenomenon and systemic sclerosis.

Authors:  B Marasini; L Conciato
Journal:  Clin Rheumatol       Date:  2001       Impact factor: 2.980

2.  Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement.

Authors:  R Livi; L Teghini; A Pignone; S Generini; M Matucci-Cerinic; M Cagnoni
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

3.  Increased finger skin vasoreactivity and stimulated vasomotion associated with simvastatin therapy in systemic sclerosis hypercholesterolemic patients.

Authors:  Marco Rossi; Laura Bazzichi; Lorenzo Ghiadoni; Ilaria Mencaroni; Ferdinando Franzoni; Stefano Bombardieri
Journal:  Rheumatol Int       Date:  2011-11-06       Impact factor: 2.631

4.  Reliability of lightguide spectrophotometry (O2C) for the investigation of skin tissue microvascular blood flow and tissue oxygen supply in diabetic and nondiabetic subjects.

Authors:  Thomas Forst; Cloth Hohberg; Eda Tarakci; Senait Forst; Peter Kann; Andreas Pfützner
Journal:  J Diabetes Sci Technol       Date:  2008-11

5.  Assessment of skin microcirculation by laser Doppler flowmetry in systemic sclerosis patients.

Authors:  Arleta Waszczykowska; Roman Goś; Elżbieta Waszczykowska; Bożena Dziankowska-Bartkowiak; Piotr Jurowski
Journal:  Postepy Dermatol Alergol       Date:  2014-02-25       Impact factor: 1.837

6.  Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study.

Authors:  Orsolya Timár; Zoltán Szekanecz; György Kerekes; Judit Végh; Anna V Oláh; Gábor Nagy; Zoltán Csiki; Katalin Dankó; Szilvia Szamosi; Ágnes Németh; Pál Soltész; Gabriella Szücs
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

7.  Microvascular Blood Flow Improvement in Hyperglycemic Obese Adult Patients by Hypocaloric Diet.

Authors:  T Mastantuono; M Di Maro; M Chiurazzi; L Battiloro; N Starita; G Nasti; D Lapi; L Iuppariello; M Cesarelli; G D'Addio; A Colantuoni
Journal:  Transl Med UniSa       Date:  2016-11-01

8.  No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis.

Authors:  Martha E Hettema; Dan Zhang; Ymkje Stienstra; Andries J Smit; Hendrika Bootsma; Cees G M Kallenberg
Journal:  Clin Rheumatol       Date:  2009-04-07       Impact factor: 2.980

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.